scispace - formally typeset
Search or ask a question
Author

George G. Guilbault

Other affiliations: Technical University of Denmark
Bio: George G. Guilbault is an academic researcher from University of New Orleans. The author has contributed to research in topics: Enzyme electrode & Immobilized enzyme. The author has an hindex of 45, co-authored 209 publications receiving 6928 citations. Previous affiliations of George G. Guilbault include Technical University of Denmark.


Papers
More filters
Journal ArticleDOI
TL;DR: A piezoelectric crystal immunobiosensor has been developed for the assay of atrazine herbicides in drinking water and is reversible, being reusable for about eight or nine assays.

162 citations

Journal ArticleDOI
TL;DR: In this article, formaldehyde dehydrogenase was placed onto a piezoelectric quartz crystal, together with the cofactors reduced glutathione and nicotinamide adenine dinucleotide; a reversible reaction with formaldehyde occurred in the gas phase.
Abstract: Formaldehyde dehydrogenase was placed onto a piezoelectric quartz crystal, together with the cofactors reduced glutathione and nicotinamide adenine dinucleotide; a reversible reaction with formaldehyde occurred in the gas phase, the frequency change of which was directly proportional to the concentration of the aldehyde. Excellent selectivity resulted, with little response to other aldehydes or alcohols (>1000:1 selectivity ratio at 1 and 10 ppm formaldehyde). 26 references, 1 figure, 4 tables.

151 citations


Cited by
More filters
Patent
30 Oct 2007
TL;DR: An analyte monitor includes a sensor, a sensor control unit, and a display unit as discussed by the authors, which is used to display an indication of a level of an analyte, based on the data obtained using the sensor.
Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.

1,856 citations

Journal ArticleDOI
TL;DR: Although wearable biosensors hold promise, a better understanding of the correlations between analyte concentrations in the blood and noninvasive biofluids is needed to improve reliability.
Abstract: Wearable biosensors are garnering substantial interest due to their potential to provide continuous, real-time physiological information via dynamic, noninvasive measurements of biochemical markers in biofluids, such as sweat, tears, saliva and interstitial fluid. Recent developments have focused on electrochemical and optical biosensors, together with advances in the noninvasive monitoring of biomarkers including metabolites, bacteria and hormones. A combination of multiplexed biosensing, microfluidic sampling and transport systems have been integrated, miniaturized and combined with flexible materials for improved wearability and ease of operation. Although wearable biosensors hold promise, a better understanding of the correlations between analyte concentrations in the blood and noninvasive biofluids is needed to improve reliability. An expanded set of on-body bioaffinity assays and more sensing strategies are needed to make more biomarkers accessible to monitoring. Large-cohort validation studies of wearable biosensor performance will be needed to underpin clinical acceptance. Accurate and reliable real-time sensing of physiological information using wearable biosensor technologies would have a broad impact on our daily lives.

1,579 citations

Journal ArticleDOI
TL;DR: This review not only offers an overview of trends in the area of pathogen detection but it also describes main techniques, traditional methods, and recent developments in the field of pathogenic bacteria biosensors.

1,334 citations

Journal ArticleDOI
TL;DR: The properties of glucose oxidase (GOD) are described in relation to the widespread use of this enzyme in biosensors, and the shortcomings of other enzymes that oxidize glucose are indicated.

1,189 citations

Journal ArticleDOI
TL;DR: In this paper, it was shown that the major ROS-generating site in mitochondria is limited to the flavin mononucleotide group (FMN) of complex I through reversed electron transfer, not at the ubiquinone of complex III.
Abstract: Generation of reactive oxygen species (ROS) by the mitochondrial electron transport chain (ETC), which is composed of four multiprotein complexes named complex I-IV, is believed to be important in the aging process and in the pathogenesis of neurodegenerative diseases such as Parkinson's disease. Previous studies have identified the ubiquinone of complex III and an unknown component of complex I as the major sites of ROS generation. Here we show that the physiologically relevant ROS generation supported by the complex II substrate succinate occurs at the flavin mononucleotide group (FMN) of complex I through reversed electron transfer, not at the ubiquinone of complex III as commonly believed. Indirect evidence indicates that the unknown ROS-generating site within complex I is also likely to be the FMN group. It is therefore suggested that the major physiologically and pathologically relevant ROS-generating site in mitochondria is limited to the FMN group of complex I. These new insights clarify an elusive target for intervening mitochondrial ROS-related processes or diseases.

1,180 citations